Journal of Asthma and Allergy
Volume 16, 2023 - Issue
Open access
502
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Tanya M Laidlaw1 Jeff and Penny Vinik Center for Allergic Diseases Research, Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, MA, USA;2 Department of Medicine, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
https://orcid.org/0000-0001-6709-9795View further author information
Andrew Menzies-Gow3 Royal Brompton and Harefield Hospitals, School of Immunology and Microbial Sciences, King’s College London, London, UKView further author information
, Scott Caveney4 Global Development, Inflammation, R&D, Amgen, Thousand Oaks, CA, USAView further author information
, Joseph K Han5 Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USAView further author information
, Nicole Martin6 Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA;7 Cytel Inc, Waltham, MA, USAView further author information
, Elliot Israel8 Divisions of Pulmonary and Critical Care Medicine and Allergy and Clinical Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
https://orcid.org/0000-0002-2470-856XView further author information
Jason K Lee9 Evidence Based Medical Educator Inc., Toronto, ON, Canada;10 Toronto Allergy and Asthma Clinic, Toronto, ON, CanadaView further author information
, Jean-Pierre Llanos11 Global Medical Affairs, Amgen, Thousand Oaks, CA, USAView further author information
, Neil Martin12 Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK;13 University of Leicester, Leicester, UKView further author information
, Ayman Megally14 Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
, Bhavini Parikh14 Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
https://orcid.org/0009-0006-7374-1274View further author information
Sylvia Vong15 Translational Science and Experimental Medicine, Early Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USAView further author information
, Tobias Welte16 Department of Respiratory Medicine and German Center for Lung Research, Hannover Medical School, Hannover, Germany
https://orcid.org/0000-0002-9947-7356View further author information
Jonathan Corren17 David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USAView further author information
show all
Pages 915-932
|
Received 11 Apr 2023, Accepted 07 Aug 2023, Published online: 04 Sep 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.